The applications of respiratory syncytial virus antigens and antibodies in therapeutic and immunological development
Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, recently there has been a surge in interest in RSV antigens, antibodies, and more in therapeutic and immunological development.
Source: news-medical.net